SCHEMBL7227602

SCHEMBL7227602

Cc1ccn2c(-c3cccc(-c4cccnc4)c3)cnc2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 5/20 0.64
GABRB3 P28472 5/20 0.64
GABRA3 P34903 4/20 0.64
GABRA1 P14867 4/20 0.60
GABRA5 P31644 3/20 0.60
GABRA2 P47869 2/20 0.60
KDR P35968 3/20 0.49
CYP2A6 P11509 2/20 0.44
BACE1 P56817 2/20 0.44
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
FLT3 P36888 1/20 0.40
FGFR3 P22607 1/20 0.40
MEN1 O00255 1/20 0.40
PSIP1 O75475 1/20 0.40
AXL P30530 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
FYN P06241 1/20 0.40
CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7233506 0.81 GABRG2 (0.62) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7232228 0.81 GABRG2 (0.61) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7234152 0.80 GABRA1 (0.60) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7231394 0.79 GABRG2 (0.56) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7226136 0.78 L3MBTL1 (0.56) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7225665 0.78 GABRA1 (0.58) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7224559 0.78 GABRA1 (0.70) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL11009952 0.77 CYP2A6 (0.46) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7231846 0.77 GABRG2 (0.56) GABRG2GABRB3GABRA3GABRA1GABRA5
SCHEMBL7224413 0.76 GABRA1 (0.67) GABRG2GABRB3GABRA3GABRA1GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642229-B2 Treatment of adverse neurological conditions MERCK SHARP & DOHME LTD. 2003-11-04 US claimed
US-6642229-B2 Treatment of adverse neurological conditions MERCK SHARP & DOHME LTD. 2003-11-04 US disclosed